Skip to main content
. 2019 Dec 10;61(1):19–27. doi: 10.4111/icu.2020.61.1.19

Fig. 2. According to concurrent androgen deprivation therapy (ADT), Kaplan–Meier survival estimates for (A) overall survival and (B) time to prostate-specific antigen (PSA) progression-free survival, and (C) radiographic progression-free survival.

Fig. 2